Drawing for AVAILOM

USPTO serial 79182507

AVAILOM

Reviewed by CopyMark Law Group

Reg. 5121574Status 706Renewal
Filing date
Status date
Registration date
Jan 17, 2017
Examiner
LEASER, ANDREW C
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with AVAILOM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson St, NWSuite 400Washington, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating [ orthopedic, ] cardiovascular [, central nervous system, pain, oncology, and nerve growth ] conditions; [ Pharmaceutical preparations for the treatment of infectious diseases; veterinary preparations for treating orthopedic, cardiovascular, central nervous system, pain, oncology, and nerve growth conditions; Veterinary preparations for the treatment of infectious diseases; veterinary vaccines; medical preparations for the treatment of wound closure, fracture repair, and for the local delivery of medications; Pharmaceutical and sanitary preparations all for medical purposes, namely, medicated skin cleansing, skin protection and skin care preparations, and medicated foot care preparations; antiseptics; medicated ointments for treating dermatological conditions; chemical preparations for sanitary purposes; chemical preparations for medical purposes, namely, for treating skin diseases and for combating skin parasites; pharmaceutical preparations for treating skin diseases and for combating skin parasites; medicated burn ointments; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, drug delivery agents in the form of a coating for tablets, powders and capsules that facilitate the delivery of a wide range of pharmaceuticals; ] amino acids for medical and veterinary purposes; [ esters, greases and oils for medical and veterinary purposes; salts, in particular sodium and potassium for medical purposes; steroids; biological preparations for medical and veterinary purposes, namely, antibacterial pharmaceuticals and antidiabetic pharmaceuticals; medicated bath preparations; therapeutic medicated bath preparations; tissues impregnated with pharmaceutical or disinfectant preparations, in particular for skin care and skin cleansing and for use as disinfectants for hygienic and sanitary purposes; ferments for pharmaceutical purposes; dietetic yeast or starch for medical use; yeast or starch for pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes; sanitary preparations for medical purposes; sanitary preparations and articles, namely, sanitary towels, sanitary napkins; sanitary preparations and articles, namely, pharmaceutical astringents, bandages for dressings, bandages for skin wounds and surgical dressings; dietetic food, substances, and preparations adapted for medical or veterinary use, namely, pasta, crackers, bread, and sugar; dietary supplements; albuminous preparations for medical purposes, namely, protein supplements; medicated confectionery; medicinal drinks; dietetic beverages adapted for medical purposes; ] medical preparations for slimming purposes; [ food for babies; ] nutritional supplements for humans; [ dietary supplements for animals; ] nutritional supplements; [ sugar, in particular candy and glucose for medical purposes; glucose for medical purposes; albuminous foodstuffs for medical purposes, namely, protein nutritional supplements; ] protein dietary supplements [ ; dietary fibre as a nutritional supplement; mineral food supplements; mineral supplements, namely, preparations of trace elements for human and animal use; vitamin preparations; medical plasters; materials for dressings, namely, gauze and wadding; material for stopping teeth; dental impression materials; dental preparations and articles, namely, adhesives for dental use, dental alloys, dental composite materials, and medicines for dental purposes; disinfectants; preparations for destroying vermin; fungicides, herbicides ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 30, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 30, 202671AGREGISTERED-SEC.71 ACCEPTED—
May 18, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 20, 2026ES71TEAS SECTION 71 RECEIVED—
Jan 17, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 18, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 18, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 23, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 23, 2023INPCINVALIDATION PROCESSED—
Apr 11, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 11, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Aug 11, 202271AGREGISTERED-SEC.71 ACCEPTED—
Aug 8, 2022EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Feb 7, 2022PUM1OFFICE ACTION ISSUED POU1—
Feb 3, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 18, 2022ES71TEAS SECTION 71 RECEIVED—
Jan 17, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 12, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 13, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 24, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 24, 2017FIMPFINAL DISPOSITION PROCESSED—
Apr 17, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 17, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 1, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 12, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 12, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 26, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 17, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 2016ALIEASSIGNED TO LIE—
Sep 6, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 26, 2016RFNPREFUSAL PROCESSED BY IB—
Mar 7, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 7, 2016RFRRREFUSAL PROCESSED BY MPU—
Mar 5, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2016DOCKASSIGNED TO EXAMINER—
Feb 23, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 17, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 11, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance